ARNA) remained flat at $2.08 during mid-day trading on Monday. The company’s stock had a trading volume of 1,900,040 shares. Arena Pharmaceuticals, Inc. has a 52-week low of $1.60 and a 52-week high of $6.28.
Ticker Report · 11/24/2015
Arena Pharmaceuticals
Top 25 S.A.F.E. Dividend Stocks » A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet …
The Street · 11/13/2015
short interest
Arena Pharmaceuticals (NASDAQ:ARNA) has earned a consensus recommendation of “Buy” from the six research firms that are covering the stock, Analyst Ratings Net reports. Three equities research analysts have rated the stock with a hold rating ...
Intercooler · 11/22/2015
Arena Pharmaceuticals
More from Bing News
Arena (NASDAQ:ARNA) investors used to look forward to seeing sales numbers ... but unless something begins to bear fruit, the idea that the stock will appreciate substantially is muted. It is also my opinion that every …
Seeking Alpha · BySpencer Osborne · 11/23/2015
Belviq Sales
Arena Pharmaceuticals (NASDAQ:ARNA) traded up 15.61% during trading on Friday, reaching $2.00. 6,203,523 shares of the company’s stock traded hands. The company has a 50 day moving average of $2.06 and a 200 day moving average of $3.33.
DC Progressive · 11/19/2015
Arena Pharmaceuticals
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock has been on quite a roller coaster ride in 2015. A few weeks ago, ARNA shares roared 76% higher in a single day after positive early-stage trials for an autoimmune disease treatment gave investors a …
Investor Place · 1/22/2015
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) list today: 2U Inc (TWOU) Antero Resources Corp (AR) Arena Pharmaceuticals, Inc. (ARNA) Aurinia Pharmaceuticals ... this free report 2U INC (TWOU): Free Stock Analysis Report ANTERO …
Yahoo Finance · 11/23/2015
Buy Stocks
ARNA stock finished the regular session at $2.20, down $0.01 (or -0.45%), and 1,334,770 of its shares exchanged hands during the day Arena Pharmaceuticals, a biopharmaceutical company, has 242.24M Shares Outstanding, Market Capitalization (intraday ...
Galaxy Stocks · 10/27/2015
Arena Pharmaceuticals, Inc. (ARNA - Analyst Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session.
ZACKS · 8/24/2015
What does the smart money think about Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)? Heading into Q2, a total of 13 of the hedge funds we track were bullish in this stock, a change of 18% from the first quarter. With hedgies’ sentiment swirling, there …
INSIDER MONKEY · 6/10/2013